Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sonya Ivanova
Observed names:
Ivanova, Sonya,
S. Ivanova,
SONYA IVANOVA
Institutions:
Medical University of Sofia,
Multiprofile Hospital for Active Treatment in Neurology and Psychiatry St. Naum
Observed institutions:
Bulgarian Academy of Sciences,
Medical University of Sofia,
Multiprofile Hospital for Active Treatment in Neurology and Psychiatry St. Naum
ORCID:
0009-0004-2525-5031
Observed ORCID:
0009-0004-2525-5031
OpenAlex ID:
A5070276002
Prevalence and Associations of Poor Sleep in Patients with Relapsing-Remitting Multiple Sclerosis on Disease-Modifying Therapy
2025
·
Dimitar Taskov
, Sonya Ivanova
, et al.
·
Journal of Clinical Medicine
·
3
PDF
Role of GM3 ganglioside in the pathology of some progressive human diseases and prognostic importance of serum anti-GM3 antibodies
2021
·
VERA KOLYOVSKA
, SONYA IVANOVA
, et al.
·
Biocell
·
2
Neurodegenerative Changes and Demyelination in Serum IgG Antibodies to GM1, GD1a and GM3 Gangliosides in Patients with Secondary Progressive Multiple Sclerosis – Preliminary Results
2019
·
Vera Kolyovska
, Sonya Ivanova
·
2
Demyelination and neurodegenerative changes in serum IgG antibodies to GM1, GD1a and GM3 gangliosides in a patient on dialysis
2017
·
Vera Kolyovska
, Velichka Pavlova
, et al.
·
Neurological Disorders and Therapeutics
·
2
PDF
From Phenotypes to Spectrum: Rethinking RRMS, SPMS and PPMS in the Era of PIRA—A Framework Integrating PIRA, Smouldering-Associated Worsening, and Neurologic Reserve to Facilitate Earlier Recognition of Progression
2026
·
Georgi V. Vasilev
, Sonya Ivanova
, et al.
·
Neurology International
·
1
PDF
Neutralizing Antibodies against Interferon‑beta in Bulgarian Adolescent Multiple Sclerosis Patients
2018
·
Sonya Ivanova
, Raliza Skrobanska
, et al.
·
1
Subjective Sleep Quality in Relation to Relapse Status in Relapsing-Remitting Multiple Sclerosis: A Propensity Score—Matched Nested Case—Control Analysis
2026
·
Dimitar Taskov
, Sonya Ivanova
, et al.
·
Neurology International
National consensus on the diagnosis and treatment of neuromyelitis optica spectrum disorders : 2025
2025
·
Milanov, Ivan
, Ivanova, Sonya
·
Movement Disorders Bulgaria
PDF
National consensus on the diagnosis and treatment of neuromyelitis optica spectrum disorders: 2023
2023
·
Milanov, Ivan
, Ivanova, Sonya
·
Movement Disorders Bulgaria
PDF
Do Binding Antibodies Predict Neutralizing Antibody Development in Multiple Sclerosis Patients?
2018
·
Sonya Ivanova
, Raliza Skrobanska
, et al.
P.1.021 The G-immunoglobulins of schizophrenic patients demonstrate proteolytic activity
2016
·
D. Parshukova
, Y. Borodyuk
, et al.
·
European Neuropsychopharmacology
Symptomatic Treatment in Multiple Sclerosis
2015
·
Sonya Ivanova
·
American Journal of Neuroprotection and Neuroregeneration
Neutralizing Antibodies: Impact on Protein-Based Disease—Modifying Therapies in Multiple Sclerosis
2015
·
Sonya Ivanova
·
American Journal of Neuroprotection and Neuroregeneration
PP08.3 – 2856: Luciferase assay to detect neutralizing antibodies in adolescent Bulgarian multiple sclerosis patients treated with interferon beta
2015
·
S. Ivanova
, I. Milanov
, et al.
·
European Journal of Paediatric Neurology
Show more works
View as search
Works count:
14
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type
